INAAT Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Isothermal Nucleic Acid Amplification Technology (INAAT) Market is segmented By Technology (Helicase-dependent Amplification(HDA), Nicking Enzyme Amplification Reaction(NEAR), Loop-mediated Isothermal Amplification(LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification(NASBA), Transcription Mediated Amplification (TMA), Single Primer Isothermal Amplification(SPIA), Other Technologies), By Product(Instruments and Reagent), By End-User (Hospital, Research laboratories, Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

INAAT Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size

Isothermal Nucleic Acid Amplification Technology (INNAT) Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 11.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Isothermal Nucleic Acid Amplification Technology (INNAT) Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Isothermal Nucleic Acid Amplification Technology Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis

The Global Isothermal Nucleic Acid Amplification Technology Market is expected to register a CAGR of 11.1% during the forecast period.

COVID-19 is expected to have a significant impact on the growth of the market. The COVID-19 pandemic observed isothermal methods implemented as a basic technology used for the diagnosis of SARS-CoV-2 RNA in home and clinical testing centers. Furthermore, in March 2020, Abbott received the United States Food and Drug Administration approval for the Emergency use of ID NOW COVID-19, an instrument-based, isothermal, rapid system for the qualitative finding of disease. Thus increased utilization during pandemic and product approvals and launches are expected to accelearte the growth of the market during the forecast period.

The increasing incidences of chronic diseases and an aging population, an increase in the adoption of INAAT over PCR, and a rise in demand for low-cost and effective diagnostics procedures are some of the major factors that are driving the growth of the market studied. According to the World Health Organization report in February 2022, Cancer was one of the major cause of death worldwide. The report states that Each year, approximately 400,000 children develop cancer in which cervical cancer is the most common in 23 countries. The report Published by International Agency for Research on Cancer (IARC) in December 2020 that the global cancer burden has risen to 19.3 million cases. and thus, due to the high prevalence of cancer around the world, the demand for effective therapy or treatment is increasing which is expected to drive the growth of the market.

Nucleic acid amplification has several applications in the healthcare industry starting from research to clinics. Until now, PCR has been the most widely-used amplification technology across the world. A thermal cycler is required in PCR, as various temperatures need to be maintained at different steps of the amplification process. Additionally, contaminants must be removed for effective amplification through this technology. The thermal cycler itself is costly, and sample preparation to remove contaminants from the sample makes the overall process more costly and time-consuming.

Owing to this high cost, the technique has witnessed limited adoption in developing countries, where the demand for this technology is extremely high, especially for clinical application. This high demand has led to the development of novel innovative techniques, such as isothermal nucleic acid amplification technology.

The isothermal technique, as the name suggests, is performed at a fixed temperature. This temperature can vary depending on the type of nucleic acid. The tedious task of preparing a sample is not required, as the technology can take a sample directly for amplification. Additionally, the technology is affordable, making it accessible for people belonging to different economic levels across the world. The low-cost associated with technology is likely to result in increased adoption, especially in the developing regions.

Hence, owing to the cost benefits and the use of novel technologies, INAAT market is expected to grow in the coming future.

Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Overview

The Isothermal Nucleic Acid Amplification Technology (INAAT) Market is consolidated in nature and consists of global players such as Becton Dickinson and Company, Qiagen NV, bioMerieux, etc. With the rising use of INAA Technology across developing countries, it is expected that few local players in countries like China, India, etc. will penetrate the market in the near future. 

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Leaders

  1. Becton Dickinson and Company

  2. Qiagen NV

  3. BioMerieux SA

  4. Quidel Corporation

  5. Tecan Genomics, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Isothermal Nucleic Acid Amplification Technology (INNAT) Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Isothermal Nucleic Acid Amplification Technology (INAAT) Market News

  • In August 2022, LGC Clinical Diagnostics announced the extension of their exclusive collaboration with Stanford Medicine's Department of Obstetrics and Gynecology and Metabolic Health Center supporting global genetic and metabolic diagnostic testing.
  • In May 2022 Meridian Bioscience launched two new innovative isothermal amplification products, Lyo-Ready Direct DNA LAMP Saliva Mix and Lyo-Ready Direct RNA/DNA LAMP saliva mix. These are used for direct detection of DNA and RNA in point of care dagnostics assays.

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Chronic Diseases And Aging Population
    • 4.2.2 Increase in the Adoption of INAAT Over PCR
    • 4.2.3 Rise In The Miniaturization of Nucleic Acid-based Diagnostics
    • 4.2.4 Rise In Demand for Low-cost And Effective Diagnostics Procedures
  • 4.3 Market Restraints
    • 4.3.1 Threatening Opposition from PCR Technologies
    • 4.3.2 Lack of Awareness about New Diagnostics Technologies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Helicase-dependent Amplification (HDA)
    • 5.1.2 Nicking Enzyme Amplification Reaction (NEAR)
    • 5.1.3 Loop-mediated Isothermal Amplification (LAMP)
    • 5.1.4 Strand Displacement Amplification (SDA)
    • 5.1.5 Nucleic Acid Sequence-based Amplification (NASBA)
    • 5.1.6 Transcription Mediated Amplification (TMA)
    • 5.1.7 Single Primer Isothermal Amplification (SPIA)
    • 5.1.8 Other Technologies
  • 5.2 By Product
    • 5.2.1 Instruments
    • 5.2.2 Reagents
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Research Laboratories
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson & Company
    • 6.1.2 BioMerieux SA
    • 6.1.3 Eiken Chemical Co. Ltd
    • 6.1.4 Lucigen
    • 6.1.5 Meridian Bioscience
    • 6.1.6 Tecan Genomics Inc.
    • 6.1.7 OptiGene Limited
    • 6.1.8 Qiagen NV
    • 6.1.9 Quidel Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Segmentation

As per the scope of the report, nucleic acid amplification technologies are used in the field of molecular biology and recombinant DNA technologies. These techniques are used as leading methods in detecting and analyzing a small number of nucleic acids. Isothermal nucleic acid amplification technology protocols are varied, and have many advantages, as it is extremely fast and does not require thermocyclers. The Isothermal Nucleic Acid Amplification Technology (INAAT) Market is segmented By Technology(Helicase-dependant Amplification(HDA), Nicking Enzyme Amplification Reaction(NEAR), Loop-mediated Isothermal Amplification(LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification(NASBA), Transcription Mediated Amplification (TMA), Single Primer Isothermal Amplification(SPIA), Other Technologies), By Product(Instruments and Reagent), By End-User (Hospital, Research laboratories, Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Technology Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Other Technologies
By Product Instruments
Reagents
By End-User Hospitals
Research Laboratories
Other End-Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Research FAQs

What is the current Global Isothermal Nucleic Acid Amplification Technology Market size?

The Global Isothermal Nucleic Acid Amplification Technology Market is projected to register a CAGR of 11.1% during the forecast period (2025-2030)

Who are the key players in Global Isothermal Nucleic Acid Amplification Technology Market?

Becton Dickinson and Company, Qiagen NV, BioMerieux SA, Quidel Corporation and Tecan Genomics, Inc. are the major companies operating in the Global Isothermal Nucleic Acid Amplification Technology Market.

Which is the fastest growing region in Global Isothermal Nucleic Acid Amplification Technology Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Isothermal Nucleic Acid Amplification Technology Market?

In 2025, the North America accounts for the largest market share in Global Isothermal Nucleic Acid Amplification Technology Market.

What years does this Global Isothermal Nucleic Acid Amplification Technology Market cover?

The report covers the Global Isothermal Nucleic Acid Amplification Technology Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Isothermal Nucleic Acid Amplification Technology Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

INAAT Industry Report

Statistics for the 2025 Global Isothermal Nucleic Acid Amplification Technology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Isothermal Nucleic Acid Amplification Technology analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.